3	the course of the study and meet the require time commitment of four day of in-person visit any concurrent fda-approved treatment for ad such a donepezil galantamine or rivastigmine and memantine must be stable for at least 2 month prior to enrollment other medication except those list under exclusion|galantamine[761,772]|||||||||C0016967|4637|4637|galantamine
3	the course of the study and meet the require time commitment of four day of in-person visit any concurrent fda-approved treatment for ad such a donepezil galantamine or rivastigmine and memantine must be stable for at least 2 month prior to enrollment other medication except those list under exclusion|donepezil[751,760]|||||||four day[671,679]||C0527316|135447|135447|donepezil
3	the course of the study and meet the require time commitment of four day of in-person visit any concurrent fda-approved treatment for ad such a donepezil galantamine or rivastigmine and memantine must be stable for at least 2 month prior to enrollment other medication except those list under exclusion|rivastigmine[776,788]|||||||||C0649350|183379|183379|rivastigmine
3	the course of the study and meet the require time commitment of four day of in-person visit any concurrent fda-approved treatment for ad such a donepezil galantamine or rivastigmine and memantine must be stable for at least 2 month prior to enrollment other medication except those list under exclusion|memantine[793,802]|||||||2 month[831,838]||C0025242|6719|6719|memantine
